Bookbuilding IPO | ₹110 Cr | Listed at BSE, NSE | Mon, Apr 10, 2006 - Mon, Apr 17, 2006
Plethico Pharmaceuticals IPO is a book build issue of ₹110.00 crores. The issue is entirely a fresh issue of 0.37 crore shares of ₹110.00 crore.
Plethico Pharmaceuticals IPO bidding started from Apr 10, 2006 and ended on Apr 17, 2006. The shares got listed on NSE and BSE on May 5, 2006.
Plethico Pharmaceuticals IPO is set final issue price at ₹300 per share.
Anand Rathi Advisors Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Plethico Pharmaceuticals IPO RHP for detailed Information.
IPO Open
Mon, Apr 10, 2006
IPO Close
Mon, Apr 17, 2006
Issue Price
₹300 per share
Market Cap (Pre-IPO)
₹1,022.00 Cr
| IPO Date | 10 to 17 Apr, 2006 |
| Listed on | Fri, May 5, 2006 |
| Face Value | ₹10 per share |
| Price Band | ₹280 to ₹300 |
| Issue Price | ₹300 per share |
| Lot Size | |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 36,66,667 shares (agg. up to ₹110 Cr) |
| Fresh Issue | 36,66,667 shares (agg. up to ₹110 Cr) |
| Share Holding Pre Issue | 3,04,00,000 shares |
| Share Holding Post Issue | 3,40,66,667 shares |
| BSE Script Code / NSE Symbol | 532739 / PLETHICO |
| ISIN | INE491H01018 |
Plethico Pharmaceuticals IPO comprises a total issue size of 36,66,667 shares. Out of which, 22,00,000 (60.00%) are allocated to QIB, 3,66,667 (10.00%) allocated to NII 11,00,000 (30.00%) allocated to RII.
| Investor Category | Shares Offered | % of Total Issue |
|---|---|---|
| QIB Shares Offered | 22,00,000 | 60.00% |
| NII (HNI) Shares Offered | 3,66,667 | 10.00% |
| Retail Shares Offered | 11,00,000 | 30.00% |
| Total Shares Offered | 36,66,667 | 100.00% |
Plethico Pharmaceuticals Limited is a healthcare company engaged in the manufacturing, marketing, and distribution of pharmaceutical and allied healthcare products.
The company operates primarily in the pharmaceutical, nutraceutical, and herbal healthcare segments, offering a wide range of products including dietary supplements, sports nutrition, herbal medicines, and OTC (over-the-counter) healthcare products.
Plethico has had a strong international presence, exporting products to multiple countries including the US, UK, and parts of Asia, and has marketed well-known brands in herbal and nutrition categories.
| Period Ended | 31 Dec 2005 | 30 Sep 2005 | 30 Sep 2004 |
|---|---|---|---|
| Assets | 366.83 | 353.39 | 279.74 |
| Total Income | 64.02 | 224.48 | 237.56 |
| NET Worth | 280.89 | 262.34 | 208.38 |
| Reserves and Surplus | 250.49 | 254.74 | 200.74 |
| Amount in ₹ Crore | |||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Upgradation of Kalaria Plant for UK MHRA compliance | 25.72 |
| 2 | Setting up of a plant in Jammu & Kashmir (J&K) which is WHO GMP compliant & undertaking Organic Farming | 30.89 |
| 3 | Setting-up of Research and Development & F&D Centre | 13.16 |
| 4 | Acquiring a stake in a OTC / Domestic herbal / Nutraceutical Company or a Brand | 28.00 |
| 5 | Setting up a Corporate Office in Mumbai | 19.40 |
| 6 | Working Capital Requirement | 27.50 |
| 7 | Expenses | 7.89 |
| Total | 152.56 |
| KPI | Sep 30, 2005 |
|---|---|
| RoNW | 21.40% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 97.5% | 87.01% |
| Market Cap | ₹1,022.00 Cr. |
The Plethico Pharmaceuticals IPO IPO subscription status. Full data available on IPOMatrix.com.
| Category | Subscription (times) | Shares Offered | Shares bid for | |
|---|---|---|---|---|
| Total | 25.31 | 36,66,667 | 9,28,18,560 | |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Management fees including fees and Underwriting Commission | 3.30 |
| 2 | Marketing and advertising expenses | 1.90 |
| 3 | Statutory, Printing and Registrar | 1.69 |
| 4 | Legal fees, Listing fees, bookbuilding charges, auditors expenses | 0.35 |
| 5 | Miscellaneous Expenses | 0.65 |
| Total | 7.89 |
| Price Details | BSE |
|---|---|
| Final Issue Price | ₹300.00 |
| Open | ₹245.00 |
| Low | ₹218.10 |
| High | ₹300.00 |
| Last Trade | ₹228.30 |
Lead Manager Reports
Plethico Pharmaceuticals IPO is a main-board IPO of 36,66,667 equity shares of the face value of ₹10 aggregating up to ₹110 Crores. The issue is priced at ₹300 per share. The minimum order quantity is .
The IPO opens on Mon, Apr 10, 2006, and closes on Mon, Apr 17, 2006.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Plethico Pharmaceuticals IPO using UPI as a payment gateway. Zerodha customers can apply in Plethico Pharmaceuticals IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Plethico Pharmaceuticals IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Plethico Pharmaceuticals IPO opens on Mon, Apr 10, 2006 and closes on Mon, Apr 17, 2006.
Plethico Pharmaceuticals IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in Plethico Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Plethico Pharmaceuticals IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Plethico Pharmaceuticals IPO allotment status.
The Plethico Pharmaceuticals IPO listing date is on Fri, May 5, 2006.
